About Us
ACT-AD is a coalition of committed national organizations seeking to accelerate development of potential cures and treatments to slow, halt or reverse the progression of Alzheimer’s disease through research. Read More
Take Action
Join ACT-AD in making the acceleration and cure for Alzheimer’s disease a national priority. Read More
About the Issue
The impact that Alzheimer’s has on individuals, families and our health care system makes the disease one of our nation’s greatest medical, social and economic challenges. There are currently 4.5 million Americans diagnosed with Alzheimer’s and by 2050 the number is expected to grow to an estimated 14 million. Read More
ACT-AD Activities
ACT-AD and our members conduct activities throughout the year to focus attention on the need to accelerate cures and treatments for Alzheimer's disease.
Latest News
| Alzheimer's / Dementia News From Medical News Today | |
| Eisai Announces The Start Of The First Clinical Study Of Ban2401, A Novel Monoclonal Antibody Targeting Neurotoxic Protofibrils Thursday, September 02, 2010 |
|
| Protein Identified That Spurs Formation Of Alzheimer's Plaques Thursday, September 02, 2010 |
|
| New Study Singles Out Factors Linked To Cognitive Deficits In Type 2 Diabetes Thursday, September 02, 2010 |
|
| ScienceDaily: Alzheimer's Research News | |
| Scientists develop new method to identify glycosylated proteins Friday, September 03, 2010 |
|
| Scientists identify protein that spurs formation of Alzheimer's plaques Thursday, September 02, 2010 |
|
| Brain exercises may slow cognitive decline initially, but speed up dementia later Wednesday, September 01, 2010 |
|
| CQ HealthBeat News | |
| Study: Many Latinos Lack Usual Health Care Provider Wednesday, August 13, 2008 |
|
| Survival Tactics By Safety Net Providers May Mean Less Free Care Tuesday, August 12, 2008 |
|
| Doggett Bill Would Remove Social Security Numbers from Medicare Cards Friday, August 08, 2008 |
|
We need your voice! The Act-AD Coalition's success depends upon the involvement of a diverse group of stakeholder organizations. Please join us in making the acceleration and cure for AD a national Priority.